Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02254785
Title Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer
Recruitment Unknown status
Gender male
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Age Groups: adult
Covered Countries CAN | AUS

No variant requirements are available.